Literature DB >> 7959644

Angiomyolipoma of the kidney. Immunoreactivity with HMB-45. Light- and electron-microscopic findings.

E Kaiserling1, S Kröber, J C Xiao, G Schaumburg-Lever.   

Abstract

Immunoreactivity with HMB-45 has recently been described in renal angiomyolipoma, a tumour of smooth muscle cells. HMB-45 is a monoclonal antibody that reacts specifically with melanosomes. In order to determine whether the tumour cells contain melanosomes and synthesize melanin, seven tumours were studied by light microscopy and immunohistochemically with the antibodies HMB-45, KP1 (CD68), PG-M1 (CD68), Ki-M1P, anti-lysozyme, anti-smooth-muscle actin, anti-vimentin, anti-S100 protein and KL1 (anti-keratin). Two tumours were also studied by electronmicroscopy and one by immuno-electronmicroscopy. Histochemical investigation for dopa oxidase was performed on cryostat sections. The tumours contained varying numbers of HMB-45-positive muscle cells. Reactivity was noted in lysosomal granules and rough endoplasmic reticulum. Typical premelanosomes were found in the tumour cells by electronmicroscopy. Groups of tumour cells stained for dopa oxidase. The tumour cells were not reactive for lysozyme, but reacted with KP1, PG-M1 and Ki-M1P. Immuno-electronmicroscopy showed that reactivity for KP1 was located within lysosomal granules. The findings show that the tumour cells of renal angiomyolipoma contain premelanosomes and that they are able to synthesize melanin, because they contain dopa oxidase. Immunoreactivity with KP1, PG-M1 and Ki-M1P can be attributed, in the absence of staining for lysozyme, to the large number of lysosomal granules. The tumour cells were not found to be related to macrophages or myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959644     DOI: 10.1111/j.1365-2559.1994.tb00596.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Perivascular epithelioid tumours (PEComas) of the gynaecological tract.

Authors:  Niamh Conlon; Robert A Soslow; Rajmohan Murali
Journal:  J Clin Pathol       Date:  2015-03-06       Impact factor: 3.411

2.  Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.

Authors:  Elena Lesma; Vera Grande; Stephana Carelli; Diego Brancaccio; Maria Paola Canevini; Rosa Maria Alfano; Guido Coggi; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms.

Authors:  J L Arbiser; R Yeung; S W Weiss; Z K Arbiser; M B Amin; C Cohen; D Frank; S Mahajan; G S Herron; J Yang; H Onda; H B Zhang; X Bai; E Uhlmann; A Loehr; H Northrup; P Au; I Davis; D E Fisher; D H Gutmann
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Trabecular angiomyolipoma mimicking hepatic cell carcinoma.

Authors:  E Székely; Z Schaff; L Madaras; P Kupcsulik; A Zsirka
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Authors:  T A Smolarek; L L Wessner; F X McCormack; J C Mylet; A G Menon; E P Henske
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo.

Authors:  J O R Hernandez; X Wang; M Vazquez-Segoviano; M Lopez-Marfil; M F Sobral-Reyes; A Moran-Horowich; M Sundberg; D O Lopez-Cantu; C K Probst; G U Ruiz-Esparza; K Giannikou; R Abdi; E P Henske; D J Kwiatkowski; M Sahin; D R Lemos
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 17.694

7.  Rapture of renal angiomyolipoma during pregnancy: a case report.

Authors:  Stylianos Kontos; Vasilios Politis; Ioannis Fokitis; Georgios Lefakis; Georgios Koritsiadis; Vasileios Simaioforidis; Stefanos Kachrilas; Evangelos Chatziplis; Sotirios Koritsiadis
Journal:  Cases J       Date:  2008-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.